Physician profile
Charles E Butler
NPI 1184710162
$227,160.46
in general payments reported to CMS, 2019-2025
15 companies · $44.64 in 2025
The $44.64 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,080 · 2020: $8,895 · 2021: $166K · 2022: $49K · 2024: $457 · 2025: $44.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $501.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $179,698.83 | 2019-2022 | |
| Allergan, INC. | $29,380.01 | 2019-2022 | |
| Davol INC. | $14,383.55 | 2019-2022 | |
| Biom'Up France Sas | $2,113.01 | 2021 | |
| Abbvie INC. | $283.47 | 2024-2025 | |
| Axogen | $265.93 | 2020-2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $263.16 | 2020-2022 | |
| Mentor Worldwide LLC | $241.51 | 2021-2022 | |
| Depuy Synthes Sales INC. | $193.25 | 2019-2021 | |
| Baxter Healthcare | $159.73 | 2019-2021 | |
| Sientra, INC. | $84.36 | 2022 | |
| Tei Biosciences INC | $30.09 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.07 | 2019 | |
| Emd Serono, INC. | $20.58 | 2019 | |
| Sanara Medtech INC. | $14.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.